Yesterday, Nov. 4, 2015, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.86 to $4,999,847.37.

Highlighted Stocks Traded by Insiders:

People's United Financial (PBCT) - FREE Research Report

Hansen Janet M, who is Director at People's United Financial, sold 10,000 shares at $16.14 on Nov. 4, 2015. Following this transaction, the Director owned 146,455 shares meaning that the stake was reduced by 6.39% with the 10,000-share transaction.

The shares most recently traded at $16.32, up $0.18, or 1.1% since the insider transaction. Historical insider transactions for People's United Financial go as follows:

  • 4-Week # shares bought: 7,600
  • 4-Week # shares sold: 4,865
  • 12-Week # shares bought: 7,600
  • 12-Week # shares sold: 4,865
  • 24-Week # shares bought: 7,600
  • 24-Week # shares sold: 4,865

The average volume for People's United Financial has been 3.7 million shares per day over the past 30 days. People's United Financial has a market cap of $5.0 billion and is part of the financial sector and banking industry. Shares are up 6.85% year-to-date as of the close of trading on Wednesday.

People's United Financial, Inc. operates as the bank holding company for People's United Bank that provides commercial banking, retail banking, and wealth management services to individual, corporate, and municipal customers. The stock currently has a dividend yield of 4.13%. The company has a P/E ratio of 19.1. Currently, there is 1 analyst who rates People's United Financial a buy, 3 analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PBCT - FREE

TheStreet Quant Ratings rates People's United Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, expanding profit margins and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full People's United Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Heritage Insurance Holdings (HRTG) - FREE Research Report

Apostolou Panagiotis, who is Director at Heritage Insurance Holdings, sold 15,044 shares at $22.08 on Nov. 4, 2015. Following this transaction, the Director owned 170,092 shares meaning that the stake was reduced by 8.13% with the 15,044-share transaction.

The shares most recently traded at $22.82, up $0.74, or 3.25% since the insider transaction. Historical insider transactions for Heritage Insurance Holdings go as follows:

  • 4-Week # shares sold: 29,044
  • 12-Week # shares sold: 49,044
  • 24-Week # shares sold: 496,025

The average volume for Heritage Insurance Holdings has been 286,600 shares per day over the past 30 days. Heritage Insurance Holdings has a market cap of $675.4 million and is part of the financial sector and insurance industry. Shares are up 10.14% year-to-date as of the close of trading on Wednesday.

Heritage Insurance Holdings, Inc. operates as a property and casualty insurance holding company in the state of Florida. The company has a P/E ratio of 7.9. Currently, there are 3 analysts who rate Heritage Insurance Holdings a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HRTG - FREE

TheStreet Quant Ratings rates Heritage Insurance Holdings as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. Get the full Heritage Insurance Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Thermo Fisher Scientific (TMO) - FREE Research Report

Harris C Martin, who is Director at Thermo Fisher Scientific, sold 531 shares at $134.35 on Nov. 4, 2015. Following this transaction, the Director owned 4,038 shares meaning that the stake was reduced by 11.62% with the 531-share transaction.

The shares most recently traded at $134.06, down $0.29, or 0.22% since the insider transaction. Historical insider transactions for Thermo Fisher Scientific go as follows:

  • 4-Week # shares sold: 3,050
  • 12-Week # shares sold: 32,607
  • 24-Week # shares sold: 47,607

The average volume for Thermo Fisher Scientific has been 2.0 million shares per day over the past 30 days. Thermo Fisher Scientific has a market cap of $53.6 billion and is part of the health care sector and health services industry. Shares are up 7.95% year-to-date as of the close of trading on Wednesday.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. The stock currently has a dividend yield of 0.45%. The company has a P/E ratio of 27.3. Currently, there are 15 analysts who rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TMO - FREE

TheStreet Quant Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, reasonable valuation levels, good cash flow from operations and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Thermo Fisher Scientific Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.